摘要
背景:噬菌体(细菌病毒)一直被作为基因治疗的载体研究。类似于其他病毒载体,噬菌体外壳蛋白已经进化了数百万年,以保护病毒基因组在注射后的降解,为有价值的治疗序列提供保护。 材料与方法:然而,将噬菌体与其他病毒基因载体分离开来的是它们对人类的安全性,以及相对容易地将外源分子在噬菌体外表面上表达,从而实现高度靶向基因传递。后者也使得噬菌体通过定向进化成为基因治疗目标发现的热门选择。虽然前景看好,噬菌体介导的基因治疗面临的几个突出的挑战,最引人注目的是较低的基因传递效率比动物病毒载体的稳定性,和nondesirable免疫刺激。 结果:本文提出了严格的审查的承诺和挑战,采用噬菌体作为基因运载工具以及介绍噬菌体的概念为基础的微生物疗法作为新的前沿和最有前途的应用噬菌体基因治疗
关键词: 微生物疗法,DNA疫苗,噬菌体疗法,bionanoparticles,溶源性细菌。
Current Gene Therapy
Title:Phage-Mediated Gene Therapy
Volume: 17 Issue: 2
关键词: 微生物疗法,DNA疫苗,噬菌体疗法,bionanoparticles,溶源性细菌。
摘要: Background: Bacteriophages (bacterial viruses) have long been under investigation as vectors for gene therapy. Similar to other viral vectors, the phage coat proteins have evolved over millions of years to protect the viral genome from degradation post injection, offering protection for the valuable therapeutic sequence.
Materials and Methods: However, what sets phage apart from other viral gene delivery vectors is their safety for human use and the relative ease by which foreign molecules can be expressed on the phage outer surface, enabling highly targeted gene delivery. The latter property also makes phage a popular choice for gene therapy target discovery through directed evolution. Although promising, phage-mediated gene therapy faces several outstanding challenges, the most notable being lower gene delivery efficiency compared to animal viruses, vector stability, and nondesirable immune stimulation. Result: This review presents a critical review of promises and challenges of employing phage as gene delivery vehicles as well as an introduction to the concept of phage-based microbiome therapy as the new frontier and perhaps the most promising application of phage-based gene therapy.Export Options
About this article
Cite this article as:
Phage-Mediated Gene Therapy, Current Gene Therapy 2017; 17 (2) . https://dx.doi.org/10.2174/1566523217666170510151940
DOI https://dx.doi.org/10.2174/1566523217666170510151940 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements